Anolik, Jennifer H <br/><br/>
The relationship of FcgammaRIIIa genotype to degree of B cell depletion by rituximab in the treatment of systemic lupus erythematosus.  [electronic resource] 

 -  Arthritis and rheumatism  Feb 2003 
 - 455-9 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0004-3591 
<br/><br/><label>Standard No.: </label>10.1002/art.10764  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antibodies, Monoclonal--administration & dosage<br/>Antibodies, Monoclonal, Murine-Derived<br/>Antineoplastic Agents--administration & dosage<br/>B-Lymphocytes--cytology<br/>Female<br/>Genotype<br/>Humans<br/>Lupus Erythematosus, Systemic--genetics<br/>Lymphocyte Count<br/>Male<br/>Receptors, IgG--genetics<br/>Rituximab